Skip to content
Screener

Stepan SCL Research Development Technical Services Expense

Research Development Technical Services Expense at other companies

SelectQuote logo
SelectQuoteSLQT
$318K-35.2%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$1.2M+71.4%
Albany International Inc. logo
Albany International Inc.AIN
$12.96M+8.9%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$6.46M+31.0%
Rockwell Automation logo
Rockwell AutomationROK
$16M+45.5%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$2.46M-63.7%

Other financials

Income statement

See full
Revenue$684.1M+15.0%
Gross profit$100.0M+39.1%
Operating income$37.2M+107%
Net income$22.9M+102%
EPS (diluted)$1.00+100%

Balance sheet

See full
Cash & equivalents$113.7M+27.9%
Total debt$707.3M-2.7%
Total equity$1.2B-2.4%
Total assets$2.4B-1.0%

Cash flow

See full
Operating cash flow$8.4M-25.3%
CapEx$23.4M-8.6%
Free cash flow-$15.0M-4.4%

Valuation

See full
Market cap$1.47B+34.1%
Enterprise value$2.07B+19.0%
P/S0.6×+0.1×

Profitability

See full
Gross margin11.8%-0.6pp
Operating margin0.8%-2.6pp
Net margin-0.1%-2.7pp
FCF margin1.5%

Returns & leverage

See full
Return on equity-0.2%-5.0pp
Debt / equity0.6×0.0×
Current ratio1.2×-0.2×

Where this comes from

Reported directly by Stepan in its filing.

Tagged under the XBRL concept scl:ResearchDevelopmentTechnicalServicesExpense.

The source filing: Stepan’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 12:37 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-334428
(In thousands, except per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Operating Expenses:
Selling14,86614,65727,03226,765
Administrative24,20322,80145,51644,215
Research, development and technical services17,19514,70132,18829,350
Deferred compensation expense1,4021,7611,964765
57,66653,920106,700101,095
Business restructuring (Note 16)5,10670,545
Operating Income (Loss)37,21017,965(12,412)46,253

Item 1 - Financial Statements

FAQ

What is Stepan's research development technical services expense?
Stepan (SCL) reported research development technical services expense of $17.2M in Q2 2026.
How has Stepan's research development technical services expense changed year-over-year?
Stepan's research development technical services expense increased by 17.0% year-over-year, from $14.7M to $17.2M.
What is the long-term trend for Stepan's research development technical services expense?
Over 4 years (2021 to 2025), Stepan's research development technical services expense has grown at a -1.4% compound annual growth rate (CAGR), from $62.69M to $59.28M.
What does research development technical services expense mean?
This metric represents the total costs incurred by a company for research, product development, and technical support services. It reflects the investment in innovation, new product formulation, and the technical expertise required to maintain competitive advantages in chemical manufacturing. Monitoring this expense helps investors assess the company's commitment to long-term growth and its ability to adapt to evolving market demands.

Ask your AI about Stepan's research development technical services expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude